Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Vizsgálati helyszín

Waikato Hospital

Hamilton, Waikato Region 3204, Új-ZélandMég nincs intézményhez kötve

50futó vizsgálat
29lezárt vizsgálat

Az itteni vizsgálatok

Miről szól a helyszín 79 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek: Idiopátiás tüdőfibrózis8 vizsgálat
Colitis ulcerosa5 vizsgálat
Peripheral artery disease5 vizsgálat
Prosztatarák5 vizsgálat
Cisztás fibrózis3 vizsgálat
Krónikus obstruktív tüdőbetegség (COPD)3 vizsgálat
Krónikus vesebetegség3 vizsgálat
Szisztémás szklerózis (szkleroderma)3 vizsgálat
Aortic aneurysm2 vizsgálat
Aortic stenosis2 vizsgálat
Crohn-betegség2 vizsgálat
Epilepszia2 vizsgálat
és még 37
Fázis: 3. fázis47 vizsgálat
2. fázis11 vizsgálat
2/3. fázis4 vizsgálat
1/2. fázis2 vizsgálat
1. fázis1 vizsgálat
Állapot: Fut, nem toboroz31 vizsgálat
Lezárult26 vizsgálat
Toboroz16 vizsgálat
Leállították3 vizsgálat
Meghívásos bevonás2 vizsgálat
Még nem toboroz1 vizsgálat
Fő szponzor: Boehringer Ingelheim12 vizsgálat
Pfizer5 vizsgálat
Hoffmann-La Roche4 vizsgálat
Janssen Research & Development, LLC4 vizsgálat
Vertex Pharmaceuticals Incorporated3 vizsgálat
és még 44

Futó vizsgálatok

Toboroz
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
ColoSeal™ ICD System Anastomotic Protection Pivotal Study
NCT07429110· Averto Medical, Inc.· Forrás
Toboroz
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT07287670· 2. fázis· Mediar Therapeutics· Forrás
Contact: Kamal Solanki (principal investigator)
Toboroz
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
NCT07472517· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
NCT07194382· 2. fázis· Avalyn Pharma Inc.· Forrás
Contact: Sandra Hopping
Toboroz
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
NCT07187531· 2. fázis· SAb Biotherapeutics, Inc.· Forrás
Contact: Noeleen Cairns
Toboroz
OM336 in Seropositive Autoimmune Diseases
NCT07229144· 1. fázis· Lakefront Biotherapeutics West LLC· Forrás
Contact: Study Sponsor
Toboroz
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT07028853· 3. fázis· Pfizer· Forrás
Toboroz
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
NCT06951217· 2. fázis· Avalyn Pharma Inc.· Forrás
Contact: Catherina Chang
Fut, nem toboroz
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
NCT06671483· 3. fázis· Takeda· Forrás
Toboroz
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
NCT06632457· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
NCT06629779· 3. fázis· Pfizer· Forrás
Toboroz
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF
NCT06384963· Ceryx Medical Australia· Forrás
Contact: Martin Stiles, MB ChB
Fut, nem toboroz
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824· 3. fázis· Boehringer Ingelheim· Forrás
Fut, nem toboroz
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State
NCT06245408· 3. fázis· Amgen· Forrás
Fut, nem toboroz
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion
NCT06029660· Shape Memory Medical, Inc.· Forrás
Fut, nem toboroz
A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
NCT05883956· 3. fázis· Otsuka Australia Pharmaceutical Pty Ltd· Forrás
Toboroz
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
NCT05943535· 3. fázis· United Therapeutics· Forrás
Contact: Sandra Hopping
Toboroz
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
NCT06016842· 3. fázis· Ipsen· Forrás
Contact: Ipsen Clinical Study Enquiries
Fut, nem toboroz
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267· 3. fázis· Teva Branded Pharmaceutical Products R&D LLC· Forrás
Fut, nem toboroz
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT05878769· 3. fázis· Hoffmann-La Roche· Forrás
Meghívásos bevonás
An Open-label Study of XEN1101 in Epilepsy
NCT05718817· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás
Fut, nem toboroz
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
NCT05757869· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).
NCT05608681· 1/2. fázis· Eupraxia Pharmaceuticals Inc.· Forrás
Contact: Heather Logan
Fut, nem toboroz
GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease
NCT05686551· 2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
ABTECT - Maintenance
NCT05535946· 3. fázis· Abivax S.A.· Forrás
Toboroz
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
NCT05623020· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
NCT05444257· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Fut, nem toboroz
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05528510· 3. fázis· Janssen Research & Development, LLC· Forrás
Meghívásos bevonás
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693· 3. fázis· United Therapeutics· Forrás
Toboroz
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743· 3. fázis· Loxo Oncology, Inc.· Forrás
Fut, nem toboroz
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
NCT05269004· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
NCT04988386· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás
Toboroz
A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
NCT03998319· 3. fázis· University of Sydney· Forrás
Contact: Sanjeevan Pasupati
Fut, nem toboroz
Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma
NCT04674683· 3. fázis· HUYABIO International, LLC.· Forrás
Fut, nem toboroz
A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)
NCT04680026· 2. fázis· HUYABIO International, LLC.· Forrás
Fut, nem toboroz
Atrasentan in Patients With IgA Nephropathy
NCT04573478· 3. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
NCT04584632· Efemoral Medical, Inc.· Forrás
Contact: Manar Khashram, MD
Fut, nem toboroz
Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks
NCT04227054· Shape Memory Medical, Inc.· Forrás
Fut, nem toboroz
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04033445· 2/3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
NCT03522246· 3. fázis· pharmaand GmbH· Forrás
Fut, nem toboroz
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT03466411· 2/3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
NCT03395197· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
The Chocolate Touch Study
NCT02924857· TriReme Medical, LLC· Forrás
Fut, nem toboroz
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
NCT02701283· Medtronic Cardiovascular· Forrás
Fut, nem toboroz
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
NCT02446405· 3. fázis· University of Sydney· Forrás
Fut, nem toboroz
Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
NCT01924819· 2/3. fázis· Australasian Gastro-Intestinal Trials Group· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Idiopátiás tüdőfibrózis4 toboroz
Szisztémás szklerózis (szkleroderma)2 toboroz
Zsírmáj (MASLD/MASH)2 toboroz
1-es típusú cukorbetegség1 toboroz
Dermatomyositis and polymyositis (myositis)1 toboroz
Eosinophilic oesophagitis1 toboroz
Epilepszia1 toboroz
Koszorúér-betegség1 toboroz
Liver cirrhosis1 toboroz
Mielóma multiplex1 toboroz
Peripheral artery disease1 toboroz
Primer biliáris cholangitis (PBC)1 toboroz
Prosztatarák1 toboroz
Szívelégtelenség1 toboroz
Tüdőrák1 toboroz

Lezárt vizsgálatok

Lezárult
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
NCT06926660· 2. fázis· Boehringer Ingelheim· Forrás
Leállították
Feasibility Study of the transShield Embolic Protection System
NCT06652841· TransAortic Medical, Inc.· Forrás
Lezárult
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
NCT06335303· 2. fázis· Boehringer Ingelheim· Forrás
Leállították
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
NCT06097260· 2. fázis· Pliant Therapeutics, Inc.· Forrás
Lezárult
Kaitoh Atherectomy FIH
NCT05873452· Terumo Medical Corporation· Forrás
Lezárult
Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
NCT05819398· 2/3. fázis· Boehringer Ingelheim· Forrás
Lezárult
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
NCT05586971· 3. fázis· LG Chem· Forrás
Lezárult
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
NCT05507216· 3. fázis· Abivax S.A.· Forrás
Lezárult
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
NCT05595642· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
NCT05559580· 2. fázis· Boehringer Ingelheim· Forrás
Lezárult
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
NCT05614063· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás
Leállították
A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)
NCT05574010· 1/2. fázis· Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA· Forrás
Lezárult
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
NCT05321069· 3. fázis· Boehringer Ingelheim· Forrás
Lezárult
Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries
NCT05556681· C. R. Bard· Forrás
Lezárult
Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System
NCT05058456· Shockwave Medical, Inc.· Forrás
Lezárult
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
NCT05014672· 2. fázis· Calliditas Therapeutics Suisse SA· Forrás
Lezárult
A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation
NCT05076149· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Lezárult
A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)
NCT05033080· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Lezárult
Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
NCT04730869· Waikato Hospital· Forrás
Lezárult
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
NCT04736199· 3. fázis· Bayer· Forrás
Lezárult
Preventing Adverse Cardiac Events in COPD
NCT03917914· 3. fázis· The George Institute· Forrás
Lezárult
A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia
NCT03734016· 3. fázis· BeiGene· Forrás
Lezárult
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
NCT03283085· 3. fázis· Shire· Forrás
Lezárult
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
NCT03020303· 3. fázis· Hamilton Health Sciences Corporation· Forrás
Lezárult
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
NCT03025308· 3. fázis· Alfasigma S.p.A.· Forrás
Lezárult
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
NCT02684006· 3. fázis· Pfizer· Forrás
Lezárult
Avelumab in First-line NSCLC (JAVELIN Lung 100)
NCT02576574· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás
Lezárult
Prospective Multi-centre Outcomes Study of Persona Knee System in Total Knee Arthroplasty
NCT04461626· Zimmer Biomet· Forrás
Lezárult
A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
NCT02100722· Stanford University· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 15.